HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Should fundoplication be added at the time of gastrostomy placement in patients who are neurologically impaired?

AbstractBACKGROUND/PURPOSE:
Patients who have advanced neurologic impairment (NI) and require gastrostomy placement (GP) frequently have symptomatic gastroesophageal reflux. We investigated the outcomes of GP without fundoplication in patients who had NI.
METHODS:
This was a retrospective review of 54 patients with NI (median, 7 years; range, 1-18 years) undergoing GP alone. The operative criteria included medically controllable or no reflux symptoms. The patients were divided into 2 groups based on the percentage of total esophageal time with a pH less than 4.0 (reflux index, or RI): group I (GI, n = 33), RI less than 5.0% (median age, 6 years; range, 2-15 years); group II (GII, n = 21), RI 5.0% or greater (median age, 10 years; range, 1-18 years). Data are expressed as medians and ranges.
RESULTS:
Nutritional management was successfully conducted after GP with or without the administration of lansoprazole, famotidine, or rikkunshito in all but 2 patients. One GI patient with alpha-thalassemia required fundoplication, and one GII patient with Cockayne syndrome required gastrojejunal tube feeding. The RI increased significantly in GI patients (2.1% [0%-4.8%] vs 4.5% [0.2%-11.4%], P = .004), whereas it decreased significantly in GII patients (11.2% [5.9%-41.6%] vs 9.8% [1.05-26.6%], P = .04).
CONCLUSION:
Gastroesophageal reflux and related symptoms rarely deteriorate to require additional treatment after GP in patients with NI. Gastrostomy placement is a less invasive and effective procedure for improving the quality of life in those patients.
AuthorsHisayoshi Kawahara, Yasuyuki Mitani, Keisuke Nose, Hiroshi Nakai, Akihiro Yoneda, Akio Kubota, Masahiro Fukuzawa
JournalJournal of pediatric surgery (J Pediatr Surg) Vol. 45 Issue 12 Pg. 2373-6 (Dec 2010) ISSN: 1531-5037 [Electronic] United States
PMID21129548 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Ulcer Agents
  • Drugs, Chinese Herbal
  • liu-jun-zi-tang
  • Famotidine
Topics
  • Adolescent
  • Anti-Ulcer Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Drugs, Chinese Herbal (therapeutic use)
  • Enteral Nutrition
  • Famotidine (therapeutic use)
  • Female
  • Fundoplication
  • Gastroesophageal Reflux (drug therapy, physiopathology, surgery)
  • Gastrostomy
  • Humans
  • Hydrogen-Ion Concentration
  • Infant
  • Male
  • Monitoring, Physiologic
  • Nervous System Diseases (complications)
  • Retrospective Studies
  • Time Factors
  • Unnecessary Procedures

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: